Be Part of the Breakthrough: EndoSound’s Wefunder Campaign Is Live

Today, EndoSound® is excited to announce our crowdfunding initiative via Wefunder, opening an opportunity for our community and supporters to invest directly in our future.

Why should you care? Our EndoSound Vision System™ (EVS™) directly impacts patient care by accelerating the diagnosis of pancreatic and liver diseases, with the potential to significantly improve clinical outcomes. The EVS enables endoscopic ultrasound (EUS) procedures to be performed efficiently in ambulatory surgical centers (ASCs) and community hospitals, offering substantial cost savings and improved accessibility for patients worldwide.

In today’s challenging capital environment, traditional funding often favors existing portfolio companies, leaving innovative startups with fewer options. Crowdfunding bridges this gap, allowing individuals to play a crucial role in advancing groundbreaking medical technology. We remain confident in our ability to secure our next round of funding, and with a successful Wefunder campaign—wefunder.com/endosound, EndoSound will be well-positioned to expand access to this critical technology.

We have chosen Wefunder for its robust platform and the unique opportunity it provides for both accredited and everyday investors to participate. So far, our friends, family, and immediate networks have shown incredible support. We’re already seeing strong traction—raising over $150,000 within just two weeks, primarily from new community investors, healthcare professionals, and even several users of the EVS. We continue to garner further interest and have a line of sight to an additional $350,000 in investments. This success has come during our “testing the waters” phase, and we are enthusiastic about our public launch on the platform today.

This crowdfunding round is a bridge toward our Series B, positioning EndoSound for further growth and innovation, especially with the upcoming release of our EVS Gen 2 product. By investing now, our community can share in our success—helping transform patient care, achieve better health outcomes, and ultimately enhance value for all stakeholders.

Join us in reshaping the future of gastroenterology through your investment and advocacy.

---